<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">35753</article-id><article-id pub-id-type="doi">10.7554/eLife.35753</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>A synthetic peptide that prevents cAMP regulation in mammalian Hyperpolarization-activated Cyclic Nucleotide-regulated (HCN) channels</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-107456"><name><surname>Saponaro</surname><given-names>Andrea</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5035-5174</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107457"><name><surname>Cantini</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107458"><name><surname>Porro</surname><given-names>Alessandro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107459"><name><surname>Bucchi</surname><given-names>Annalisa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107460"><name><surname>DiFrancesco</surname><given-names>Dario</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107461"><name><surname>Maione</surname><given-names>Vincenzo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8229-6612</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107462"><name><surname>Donadoni</surname><given-names>Chiara</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107463"><name><surname>Introini</surname><given-names>Bianca</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40816"><name><surname>Mesirca</surname><given-names>Pietro</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8857"><name><surname>Mangoni</surname><given-names>Matteo Elia</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8892-3373</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13658"><name><surname>Thiel</surname><given-names>Gerhard</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42357"><name><surname>Banci</surname><given-names>Lucia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107464"><name><surname>Santoro</surname><given-names>Bina</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-106535"><name><surname>Moroni</surname><given-names>Anna</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1860-406X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biosciences</institution>, <institution>University of Milan</institution>, <addr-line><named-content content-type="city">Milan</named-content></addr-line>, <country>Italy</country></aff><aff id="aff2"><institution content-type="dept">Centro Risonanze Magnetiche (CERM)</institution>, <institution>University of Florence</institution>, <addr-line><named-content content-type="city">Florence</named-content></addr-line>, <country>Italy</country></aff><aff id="aff3"><institution content-type="dept">Institut de Génomique Fonctionnelle</institution>, <institution>Université de Montpellier, CNRS, INSERM</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">Department of Biology</institution>, <institution>Technische Universität Darmstadt</institution>, <addr-line><named-content content-type="city">Darmstadt</named-content></addr-line>, <country>Germany</country></aff><aff id="aff5"><institution content-type="dept">Department of Neuroscience</institution>, <institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1079"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Reviewing editor</role><aff><institution>J.W. Goethe-University</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>anna.moroni@unimi.it</email> (AM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>06</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e35753</elocation-id><history><date date-type="received"><day>07</day><month>02</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>06</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Saponaro et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Saponaro et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-35753-v1.pdf"/><abstract><p>Binding of TRIP8b to the cyclic nucleotide binding domain (CNBD) of mammalian HCN channels prevents their regulation by cAMP. Since TRIP8b is expressed exclusively in the brain, we envisage that it can be used for orthogonal control of HCN channels beyond the central nervous system. To this end, we have identified by rational design a 40-aa long peptide (TRIP8b<sub>nano</sub>) that recapitulates affinity and gating effects of TRIP8b in HCN isoforms (human hHCN1, mHCn2, rbHCN4) and in the cardiac current I<sub>f </sub>in rabbit and mouse sinoatrial node cardiomyocytes. Guided by a NMR-derived structural model that identifies the key molecular interactions between TRIP8b<sub>nano</sub> and HCN CNBD, we further designed a cell-penetrating peptide (TAT-TRIP8b<sub>nano</sub>) which successfully prevented b-adrenergic activation of mouse I<sub>f</sub> leaving the stimulation of the L-type calcium current (I<sub>CaL</sub>) unaffected. TRIP8b<sub>nano</sub> represents a novel approach to selectively control HCN activation, which yields the promise of a more targeted pharmacology compared to pore blockers.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002803</institution-id><institution>Fondazione Cariplo</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Moroni</surname><given-names>Anna</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Moroni</surname><given-names>Anna</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Moroni</surname><given-names>Anna</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Experiments on rabbit SAN cells were performed using left-over cells obtained during experiments approved by the Animal Welfare Body of the University of Milan and by the Italian Ministry of Health (license n.1127/2015-PR).  Animal procedures were conformed to the guidelines of the care and use of laboratory animals established by Italian and European Directives (D. Lgs no 2014/26, 2010/63/UE).Mouse primary pacemaker cells were isolated from adult C5B6/J mice as previously described (Mangoni and Nargeot, Cardiovasc Res 2001), in accordance with  the Guide for the Care and Use of Laboratory Animals (eighth edition, 2011), published by the US National Institute of Health and European directives (2010/63/EU). The protocol was approved by the ethical committee of the University of Montpellier and the French Ministry of Agriculture (protocol N{degree sign}: 2017010310594939).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 3.</p></sec><supplementary-material><ext-link xlink:href="elife-35753-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>